Dubduban, Baby Boy .
HRN: 23-07-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
CEFTAZIDIME 1GM (VIAL)
05/29/2023
06/04/2023
IV
96mg
Q12Hrs
Thickly MSAF
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes